E Fund Management Co., Ltd. Rhythm Pharmaceuticals, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.6 Billion
- Q1 2024
A detailed history of E Fund Management Co., Ltd. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 10,333 shares of RYTM stock, worth $436,879. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,333
Previous 6,533
58.17%
Holding current value
$436,879
Previous $300,000
49.0%
% of portfolio
0.03%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding RYTM
# of Institutions
176Shares Held
62.4MCall Options Held
880KPut Options Held
84.1K-
Primecap Management CO Pasadena, CA7.75MShares$328 Million0.25% of portfolio
-
Black Rock Inc. New York, NY6.53MShares$276 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$271 Million3.51% of portfolio
-
Goldman Sachs Group Inc New York, NY5.11MShares$216 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.3MShares$140 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.36B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...